Legend Biotech Corporation (LEGN) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Seeking Alpha
Jessie Yeung - Vice President of Finance, Investor & Public Relations Ying Huang - CEO & Director Alan Bash - President of CARVYKTI® Carlos Santos - Chief Financial Officer Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Jonathan Miller - Evercore ISI Institutional Equities, Research Division Linhai Zhao - Goldman Sachs Group, Inc., Research Division Eric Schmidt - Cantor Fitzgerald & Co., Research Division Konstantinos Biliouris - Oppenheimer & Co. Inc., Research Division James Shin - Deutsche Bank AG, Research Division Sean McCutcheon - Raymond James & Associates, Inc., Research Division Leonid Timashev - RBC Capital Markets, Research Division Presentation Operator Good day, and welcome to the Legend Fourth Quarter 2025 Earnings Call. [Operator Instructions] Please note, this call is being recorded. I'd now like to turn the call over to Jessie Yeung, Vice President of Investor Relations and Finance. Please go ahead. Jes
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
- Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ... [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (LEGN) was upgraded by Truist Financial Corporation from "hold" to "strong-buy".MarketBeat
LEGN
Sec Filings
- 3/10/26 - Form 20-F
- 3/10/26 - Form 6-K
- 2/6/26 - Form 6-K
- LEGN's page on the SEC website